Is Glenmark Pharmaceuticals Limited stock a buy or sell right now?

Glenmark Pharmaceuticals Limited currently trades in a Neutral range, with momentum and trend indicators showing no clear direction.

What is Glenmark Pharmaceuticals Limited’s RSI?

RSI is 52.15, showing balanced momentum within the normal range.

What does MACD indicate for GLENMARK.NS?

MACD at 22.92 remains positive, but the signal line crossover suggests short-term caution.

What are Glenmark Pharmaceuticals Limited’s key support and resistance levels?

Support sits around $2260.28, while resistance is near $2453.58.

Glenmark Pharmaceuticals Limited

GLENMARK.NS•NSE

Healthcare

Drug Manufacturers - Specialty & Generic

₹2351.40

₹92.30(4.09%)

Indian Market opens in 10h 39m

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Glenmark Pharmaceuticals Limited (NSE:GLENMARK.NS).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

GLENMARK.NS Technical Analysis Summary

Glenmark Pharmaceuticals Limited stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral

Momentum:Neutral to Bullish (RSI: 52.15)

Trend Strength:Weak (ADX: 19.68)

Volatility:Medium (ATR: 77.30)

Support/Resistance:$2260.28 – $2453.58 (Bollinger Bands)

This mix signals that Glenmark Pharmaceuticals Limited is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 52.15

Bullish

Above midpoint suggests upward bias.

Stochastic %K: 47.72

Neutral

Mid-range signal with no clear trend.

Williams %R: -48.20

Neutral

Balanced market without strong signals.

Rate of Change (ROC): -3.35

Bearish

Selling pressure outweighs buying.

Takeaway:Glenmark Pharmaceuticals Limited shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: 22.92

Bullish

Bullish, trend momentum is strengthening.

ADX: 19.68

Weak

Weak trend, market trading sideways.

ATR (14): 77.30

Rising

Rising volatility, market activity increasing.

CCI (14): -43.95

Bearish

Bearish, momentum remains under pressure.

Takeaway:Glenmark Pharmaceuticals Limited shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators

Bollinger Bands

Upper Band

$2453.58

Middle Band (SMA 20)

$2356.93

Lower Band

$2260.28

Current Position

Within Bands

Takeaway:Glenmark Pharmaceuticals Limited trades closer to support, showing weaker momentum within bands.

Keltner Channels

Upper Channel

$2483.75

Middle Line (EMA 20)

$2329.15

Lower Channel

$2174.55

Squeeze Status

Squeeze On

Takeaway:Glenmark Pharmaceuticals Limited trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis

On-Balance Volume2.60M

Money Flow Index43.92Neutral, balanced money flows with no clear signal.

Relative Vigor Index55.18Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:GLENMARK.NS shows mixed signals in money flow analysis.

Technical Trading Signals Summary

Based on the current technical analysis of Glenmark Pharmaceuticals Limited, here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

Overall Recommendation:Technical indicators for Glenmark Pharmaceuticals Limited are mixed, suggesting a Hold or wait-and-see approach.